Skip to main content

Cambridge Advisors Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1633695 OMAHA, NE

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026
Position Value
$284,265
-$29,317 QoQ
Shares Held
2,250
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,683
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Cambridge Advisors Inc. holds $16,674,467 across 6 Drug Manufacturers - General names. GILD ranks #6 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
2,250 $284,265

All Filings in GILD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $284,265 2,250
2026-03-31 $313,582 2,250
2025-12-31 $276,165 2,250
2025-09-30 $249,750 2,250
2025-06-30 $271,631 2,450
2025-03-31 $274,522 2,450
2024-12-31 $226,306 2,450
2024-09-30 $222,176 2,650
2023-12-31 $214,676 2,650
2023-09-30 $231,564 3,090
2023-06-30 $238,146 3,090
2023-03-31 $256,377 3,090
2022-12-31 $265,276 3,090
2022-09-30 $647,128 10,490
2022-06-30 $642,205 10,390
2022-03-31 $629,575 10,590
2021-12-31 $809,601 11,150
2021-09-30 $792,797 11,350
2021-06-30 $781,561 11,350
2021-03-31 $754,232 11,670
2020-12-31 $534,244 9,170
2020-09-30 $593,227 9,388
2020-06-30 $734,623 9,548
2020-03-31 $655,869 8,773